Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

ClinicalTrials.gov ID: NCT07365826

Public ClinicalTrials.gov record NCT07365826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 Concomitantly Administered With Seasonal Influenza Vaccine in Healthy Subjects 50 Years of Age and Older

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, randomized, double-blind study to evaluate the safety and immunogenicity of VAX-31 and seasonal influenza vaccine in pneumococcal-naïve adults ≥ 50 years when the two vaccines are administered at the same visit or separately.

Study identification

NCT ID
NCT07365826
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vaxcyte, Inc.
Industry
Enrollment
1,390 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2026 (Actual)
Primary completion
Mar 2027 (Estimated)
Completion
Mar 2027 (Estimated)
Last update posted
Jun 30, 2026

2026 – 2027

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Hope Research Institute Phoenix Arizona 85032 —
Tekton Research at Fort Collins Fort Collins Colorado 80525 —
University Clinical Research - Deland DeLand Florida 32720-0834 —
CenExel Research Centers of America Hollywood Florida 33024 —
Health Awareness Jupiter Florida 33458 —
Accel Research Sites - Lakeland Lakeland Florida 33803 —
Accel Research Sites - Largo Largo Florida 33777 —
Precision Clinical Research Sunrise Florida 33351 —
Velocity Valparaiso Valparaiso Indiana 46383 —
Johnson County ClinTrials Lenexa Kansas 66219 —
AMR Lexington Lexington Kentucky 40509 —
DM Clinical Research - Detroit Detroit Michigan 48076 —
Velocity Omaha Omaha Nebraska 68134 —
Rochester Clinical Research Rochester New York 14609 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Coastal Carolina Research Center North Charleston South Carolina 29405 —
DelRicht Research - Hendersonville Hendersonville Tennessee 37075 —
AMR Knxoville Knoxville Tennessee 37909 —
Tekton Research at Austin Austin Texas 78745 —
REX Clinical Trials Beaumont Texas 77701 —
Epic Medical Research DeSoto Texas 75115 —
CenExel JBR Clinical Research Salt Lake City Utah 84107 —
Charlottesville Medical Research Center Charlottesville Virginia 22911 —
Health Research of Hampton Roads, Inc. Newport News Virginia 23606 —
Clinical Research Partners, LLC. Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07365826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 30, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07365826 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →